Company intelligence / Profile preview

Next Genomix Laboratories

Norcross, Georgia, United Statesnextgenomixlab.com ↗

Ownership: Private
Development stage: Commercial

Overview

Next Genomix Laboratories provides high-complexity clinical laboratory services focused on precision diagnostics. Their offerings include pharmacogenomics testing for personalized medication selection/dosing, epidermal nerve fiber density testing for small fiber peripheral neuropathy diagnosis, advanced PCR-based pathogen detection for wounds/nails with antimicrobial resistance profiling. The company leverages information technology and AI to deliver actionable results to healthcare providers

Therapeutic areas: EndocrinologyPsychiatryGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Diagnostic testPCR-based assayGenetic testing (Pharmacogenomics)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Next Genomix Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Next Genomix Laboratories.

Explore the full profile